[Federal Register Volume 75, Number 237 (Friday, December 10, 2010)]
[Notices]
[Page 76993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-31066]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0001]
Tobacco Products Scientific Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Tobacco Products Scientific Advisory
Committee.
General Function of the Committee: To provide advice and
recommendations to the Agency on FDA's regulatory issues.
Date and Time: The meeting will be held on January 10 and 11,
2011 from 8 a.m. until 5 p.m.
Location: FDA White Oak Conference Center, Bldg. 31, rm. 1503,
10903 New Hampshire Ave., Silver Spring, MD 20993-0002. Information
regarding special accommodations due to a disability, visitor
parking and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/default.htm; under the heading ``Resources for
You,'' click on ``White Oak Conference Center Parking and
Transportation Information for FDA Advisory Committee Meetings.''
Please note that visitors to the White Oak Campus must have a valid
driver's license or other picture ID, and must enter through
Building 1.
Contact Person: Caryn Cohen, Office of Science, Center for
Tobacco Products, Food and Drug Administration, 9200 Corporate
Blvd., Rockville, MD 20850, 1-877-287-1373 (choose Option 4), e-
mail: [email protected], or FDA Advisory Committee Information Line,
1-800-741-8138 (301-443-0572 in the Washington, DC area), code
8732110002. Please call the Information Line for up-to-date
information on this meeting. A notice in the Federal Register about
last minute modifications that impact a previously announced
advisory committee meeting cannot always be published quickly enough
to provide timely notice. Therefore, you should always check the
Agency's Web site and call the appropriate advisory committee hot
line/phone line to learn about possible modifications before coming
to the meeting.
Agenda: On January 10 and 11, 2011, the Committee will continue
to (1) receive updates from the Menthol Report Subcommittee and (2)
receive and discuss presentations regarding the data requested by
the Committee at the March 30 and 31, 2010, meeting of the Tobacco
Products Scientific Advisory Committee.
FDA intends to make background material available to the public
no later than 2 business days before the meeting. If FDA is unable
to post the background material on its Web site prior to the
meeting, the background material will be made publicly available at
the location of the advisory committee meeting, and the background
material will be posted on FDA's Web site after the meeting.
Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
December 30, 2010. Oral presentations from the public will be
scheduled between approximately 3 p.m. and 4 p.m. on January 10,
2011. Those individuals interested in making formal oral
presentations should notify the contact person and submit a brief
statement of the general nature of the evidence or arguments they
wish to present, the names and addresses of proposed participants,
and an indication of the approximate time requested to make their
presentation on or before December 21, 2010. Time allotted for each
presentation may be limited. If the number of registrants requesting
to speak is greater than can be reasonably accommodated during the
scheduled open public hearing session, FDA may conduct a lottery to
determine the speakers for the scheduled open public hearing
session. The contact person will notify interested persons regarding
their request to speak by December 22, 2010.
Persons attending FDA's advisory committee meetings are advised
that the Agency is not responsible for providing access to
electrical outlets.
FDA welcomes the attendance of the public at its advisory
committee meetings and will make every effort to accommodate persons
with physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Caryn Cohen at
least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory
committee meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for
procedures on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: December 3, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-31066 Filed 12-9-10; 8:45 am]
BILLING CODE 4160-01-P